NAMS stock
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) institutional holders · rev $22.5M
No 13F filings for quarters ended 2026-06-30 or later list NewAmsterdam Pharma Company N.V. Ordinary Shares yet.
No current-quarter 13F holders on file for NAMS yet.
These 13F holders as JSON? API free 100/dayNAMS institutional holders FAQ
What is NAMS's latest revenue?
Latest cached NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) revenue for Dec 31, 2025 was $22.5M. Statements: https://lician.com/financials/nams
Not investment advice. Figures as filed or reported, not a live feed.